keyword
https://read.qxmd.com/read/38618171/somatomotor-visual-resting-state-functional-connectivity-increases-after-2-years-in-the-uk-biobank-longitudinal-cohort
#1
JOURNAL ARTICLE
Anton Orlichenko, Kuan-Jui Su, Hui Shen, Hong-Wen Deng, Yu-Ping Wang
PURPOSE: Functional magnetic resonance imaging (fMRI) and functional connectivity (FC) have been used to follow aging in both children and older adults. Robust changes have been observed in children, in which high connectivity among all brain regions changes to a more modular structure with maturation. We examine FC changes in older adults after 2 years of aging in the UK Biobank (UKB) longitudinal cohort. APPROACH: We process fMRI connectivity data using the Power264 atlas and then test whether the average internetwork FC changes in the 2722-subject longitudinal cohort are statistically significant using a Bonferroni-corrected <mml:math xmlns:mml="https://www...
March 2024: Journal of Medical Imaging
https://read.qxmd.com/read/38616308/frontline-combination-of-dasatinib-and-low-intensity-chemotherapy-in-adults-with-de-novo-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia
#2
JOURNAL ARTICLE
Yizhou Peng, Jinjin Huang, Jin Yin, Fankai Meng, Yang Cao, Liang Huang, Dengju Li, Yicheng Zhang, Donghua Zhang, Li Meng, Zhiqiang Han, Zhenya Hong
BACKGROUND: Studies on dasatinib-based low-intensity induction regimens and post-remission strategies are limited in China. Therefore, we conducted a single-center phase 2 trial in newly diagnosed adult patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) to establish the efficacy and safety of this treatment approach. RESEARCH DESIGN AND METHODS: Patients received one month of dasatinib plus low-intensity chemotherapy and two months of dasatinib monotherapy for induction, followed by a single course of high-dose methotrexate for consolidation...
April 14, 2024: Expert Review of Hematology
https://read.qxmd.com/read/38615413/-instead-of-just-taking-my-baby-they-could-ve-actually-given-me-a-chance-experiences-with-plans-of-safe-care-among-birth-parents-impacted-by-perinatal-substance-use
#3
JOURNAL ARTICLE
Yuan He, Barbara H Chaiyachati, Meredith Matone, Shelley Bastos, Stacey Kallem, Aasta Mehta, Joanne N Wood
BACKGROUND: Federal legislation mandates healthcare providers to notify child protective service (CPS) agencies and offer a voluntary care plan called a "plan of safe care" (POSC) for all infants born affected by prenatal substance use. While POSCs aim to provide supportive services for families impacted by substance use, little is known about birth parents' perceptions and experiences. OBJECTIVE: To examine birth parents' perceptions and experiences regarding POSC...
April 13, 2024: Child Abuse & Neglect
https://read.qxmd.com/read/38606487/covid-19-and-asthma-onset-in-children
#4
JOURNAL ARTICLE
James P Senter, Laura K Aisenberg, Jesse W Dudley, Xianqun Luan, Jing Huang, Chén C Kenyon, David A Hill
BACKGROUND AND OBJECTIVES: Respiratory viral infections increase risk of asthma in infants and children. Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can cause severe lung inflammation and prolonged respiratory symptoms. We sought to determine whether SARS-CoV-2 infection modified pediatric incident asthma risk. METHODS: This retrospective cohort study examined children ages 1 to 16 within the Children's Hospital of Philadelphia Care Network who received polymerase chain reaction (PCR) testing for SARS-CoV-2 between March 1, 2020 and February 28, 2021...
April 12, 2024: Pediatrics
https://read.qxmd.com/read/38581291/a-review-of-immunotargeted-therapy-for-philadelphia-chromosome-positive-acute-lymphoblastic-leukaemia-making-progress-in-chemotherapy-free-regimens
#5
REVIEW
Zhen-Yu Xiong, Yao-Jia Shen, Shi-Zhong Zhang, Hong-Hu Zhu
Philadelphia chromosome-positive acute lymphoblastic leukemia (PH + ALL) is the most common cytogenetic abnormality of B-ALL in adults and is associated with poor prognosis. Previously, the only curative treatment option in PH + ALL was allogeneic hematopoietic stem cell transplantation (Allo-HSCT). Since 2000, targeted therapy combined with chemotherapy, represented by the tyrosine kinase inhibitor Imatinib, has become the first-line treatment for PH + ALL. Currently, the remission rate and survival rate of Imatinib are superior to those of simple chemotherapy, and it can also improve the efficacy of transplantation...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38577721/involvement-of-bcr-abl1-in-laminin-adhesion-of-philadelphia-chromosome-positive-%C3%A2-acute-lymphoblastic-leukemia-through-upregulation-of-integrin-%C3%AE-6
#6
JOURNAL ARTICLE
Kazuya Takahashi, Thao Thu Thi Nguyen, Atsushi Watanabe, Hiroki Sato, Kinuko Saito, Minori Tamai, Daisuke Harama, Shin Kasai, Koshi Akahane, Kumiko Goi, Keiko Kagami, Masako Abe, Chiaki Komatsu, Yasuhiro Maeda, Kanji Sugita, Takeshi Inukai
BACKGROUND: Adhesion of cancer cells to extracellular matrix laminin through the integrin superfamily reportedly induces drug resistance. Heterodimers of integrin α6 (CD49f) with integrin β1 (CD29) or β4 (CD104) are major functional receptors for laminin. Higher CD49f expression is reportedly associated with a poorer response to induction therapy in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Moreover, a xenograft mouse model transplanted with primary BCP-ALL cells revealed that neutralized antibody against CD49f improved survival after chemotherapy...
April 2024: Cancer reports
https://read.qxmd.com/read/38572397/a-rare-case-of-philadelphia-positive-p210bcr-abl1-t-cell-acute-lymphoblastic-leukemia-lymphoma-associated-with-minimal-residual-disease-persistence-after-intensive-chemotherapeutic-approaches
#7
Shruti Shah, Rupayan Kundu, Rahul Mishra, Sudipto Mukherjee, Abhay Singh
T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a rare and aggressive leukemia. Philadelphia chromosome-positive cytogenetic abnormality is most common in CML. It is difficult to differentiate between de novo Ph+ T-ALL/LBL and T-cell lymphoblastic crises of CML. We present a case of adult Ph+ T-ALL/LBL with a likely history of antecedent CML. Initially thought to be a case of chronic-phase CML, a diagnostic quandary led to the pursuit of a lymph node biopsy that established the diagnosis of Ph+ T-LBL or T lymphoblastic blast crisis of CML, a clinical presentation extremely rare and only the second of its kind from our review of the literature...
2024: Leukemia Research Reports
https://read.qxmd.com/read/38566805/ponalfil-trial-for-adults-with-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-long-term-results
#8
JOURNAL ARTICLE
Josep-Maria Ribera, Mireia Morgades, Jordi Ribera, Pau Montesinos, Isabel Cano-Ferri, Pilar Martínez, Jordi Esteve, Daniel Esteban, María García-Fortes, Natalia Alonso, José González-Campos, Arancha Bermúdez, Anna Torrent, Eulàlia Genescà, Clara Maluquer, Joaquín Martínez-López, Ramón García-Sanz
No abstract text is available yet for this article.
April 2024: HemaSphere
https://read.qxmd.com/read/38564221/automated-text-message-based-program-and-use-of-acute-health-care-resources-after-hospital-discharge-a-randomized-clinical-trial
#9
JOURNAL ARTICLE
Eric Bressman, Judith A Long, Robert E Burke, Aiden Ahn, Katherine Honig, Jarcy Zee, Nancy McGlaughlin, Mohan Balachandran, David A Asch, Anna U Morgan
IMPORTANCE: Postdischarge outreach from the primary care practice is an important component of transitional care support. The most common method of contact is via telephone call, but calls are labor intensive and therefore limited in scope. OBJECTIVE: To test whether a 30-day automated texting program to support primary care patients after hospital discharge reduces acute care revisits. DESIGN, SETTING, AND PARTICIPANTS: A 2-arm randomized clinical trial was conducted from March 29, 2022, through January 5, 2023, at 30 primary care practices within a single academic health system in Philadelphia, Pennsylvania...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38556836/therapy-related-acute-lymphoblastic-leukaemia-in-women-with-antecedent-breast-cancer
#10
JOURNAL ARTICLE
Hoda Pourhassan, Jianying Zhang, Jose Tinajero, Vinod Pullarkat, Vaibhav Agrawal, Paul Koller, Monzr Al Malki, Ahmed Aribi, Amandeep Salhotra, Karamjeet Sandhu, Haris Ali, Anthony Stein, Guido Marcucci, Stephen Forman, Ibrahim Aldoss
Therapy-related acute lymphoblastic leukaemia (tr-ALL) is a disease entity attributed to previous exposure to chemotherapy and/or radiation for antecedent malignancy. There is observed female predominance for tr-ALL, likely due to high prevalence and excellent curable rate for non-metastatic breast cancer as well as the frequent use of carcinogenic agents as part of adjuvant therapy. Here, we reviewed 37 women with diagnosis of ALL following breast cancer treatment with focus on cytogenetic categorization. Philadelphia chromosome positivity (Ph+), KMT2A alterations and other cytogenetic change groups were observed in 32%, 22% and 46% of patients respectively...
March 31, 2024: British Journal of Haematology
https://read.qxmd.com/read/38556661/surgical-management-of-vascular-malformations-of-the-upper-extremity-a-12-year-retrospective-cohort-study
#11
JOURNAL ARTICLE
Sophia Hu, Tessa E Muss, Yoshiko Toyoda, Mimi S Kim, Ashley E Chang, Manisha Banala, Emily M Graham, Deepthi Gunturi, Ines C Lin
INTRODUCTION: Vascular malformations (VMs) typically appear at birth and grow commensurately with patients. They can vary broadly in vessel type and tissue involvement, and upper extremity (UE) VMs can pose unique functional and aesthetic challenges in children. Given the advent of operative and nonoperative technologies like sclerotherapy and medications, a contemporary review of the surgical management of UE VMs is warranted. METHODS: We performed a retrospective review of all patients who had surgical management of VMs from 2010 to 2021 at The Children's Hospital of Philadelphia...
April 1, 2024: Annals of Plastic Surgery
https://read.qxmd.com/read/38556438/evaluating-the-role-of-chatgpt-as-a-study-aid-in-medical-education-in-surgery
#12
JOURNAL ARTICLE
Tarek Araji, Ari D Brooks
OBJECTIVE: Our aim was to assess how ChatGPT compares to Google search in assisting medical students during their surgery clerkships. DESIGN: We conducted a crossover study where participants were asked to complete 2 standardized assessments on different general surgery topics before and after they used either Google search or ChatGPT. SETTING: The study was conducted at the Perelman School of Medicine at the University of Pennsylvania (PSOM) in Philadelphia, Pennsylvania...
March 30, 2024: Journal of Surgical Education
https://read.qxmd.com/read/38556342/ponatinib-related-vasospastic-angina
#13
JOURNAL ARTICLE
Michiho Shindo, Chinatsu Komiyama, Tetsuo Yamaguchi, Kosei Kageyama, Hisashi Yamamoto, Yo Fujimoto, Naoyuki Uchida, Takahide Kodama
Tyrosine kinase inhibitors (TKIs) are essential drugs for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Cardiovascular or arteriothrombotic adverse events have been reported in patients treated with TKIs. We report 3 cases of Ponatinib-related vasospastic angina, in which prophylactic administration of nitrates or calcium channel blockers was effective.
2024: International Heart Journal
https://read.qxmd.com/read/38550770/archived-cytogenetic-cell-pellets-used-to-detect-a-bcr-abl1-driver-mutation-eight-years-before-disease-presentation
#14
Ramakrishnan Sasi, Michelle Spruill, Peter L Perrotta
Evidence suggests that the earliest genetic events in the evolution of a cancer can predate diagnosis by several years or decades. In chronic myeloid leukemia (CML), the BCR::ABL1 fusion driver mutation can be present for an extended period before clinical disease manifests. The time between the BCR::ABL1 occurrence and symptom onset is referred to as the latency period. Though modeling studies predict this latency period is no more than ten years, it is still unclear how long it can be. We present a case of a patient referred for suspected CML...
2024: Case Reports in Hematology
https://read.qxmd.com/read/38543121/long-term-follow-up-of-blinatumomab-in-older-patients-with-b-cell-acute-lymphoblastic-leukemia
#15
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Older adults who are diagnosed with acute lymphoblastic leukemia (ALL) and are treated with chemotherapy generally have poor outcomes. Blinatumomab is a CD19/CD3 bispecific T-cell engager that has been approved for the treatment of B-cell ALL in the relapsed/refractory setting or in patients with minimal residual disease (MRD) positivity. We previously reported on a small cohort of older adults with newly diagnosed Philadelphia chromosome negative B-cell ALL who were treated with blinatumomab monotherapy in the first line setting...
March 5, 2024: Pharmaceuticals
https://read.qxmd.com/read/38537997/acute-lymphoblastic-leukemia-with-near-haploid-karyotype-and-philadelphia-chromosome
#16
JOURNAL ARTICLE
Ioannis Panagopoulos, Kristin Andersen, Hilde Skuterud Wik, Maren Randi Tandsæther
BACKGROUND/AIM: In precursor B-cell lineage acute lymphoblastic leukemia (BCP-ALL), leukemic cells harbor genetic abnormalities that play an important role in the diagnosis, prognosis, and treatment. A subgroup of BCP-ALL is characterized by the presence of a Philadelphia (Ph) chromosome and a chimeric BCR::ABL1 gene, whereas in another subgroup, leukemic cells exhibit near-haploidy with chromosome number 24-30. This study presents the third documented case of BCP-ALL in which a near haploid clone concurrently displayed a Ph chromosome/BCR::ABL1...
April 2024: Anticancer Research
https://read.qxmd.com/read/38528751/a-case-of-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-with-coexistence-of-jak2-v617f-clone
#17
JOURNAL ARTICLE
Li-Li Han, Haiping Dai, Xia Yang, Junfeng Zhu
No abstract text is available yet for this article.
March 26, 2024: Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology
https://read.qxmd.com/read/38526239/outcomes-and-adverse-events-in-older-acute-lymphoblastic-leukemia-patients-treated-with-a-pediatric-inspired-protocol-with-pegylated-or-native-asparaginase
#18
JOURNAL ARTICLE
Maria Agustina Perusini, Claire Andrews, Eshetu G Atenafu, Vikas Gupta, Dawn Maze, Andre C Schuh, Karen Wl Yee, Aniket Bankar, Marta B Davidson, Guillaume Richard-Carpentier, Steven M Chan, Jad Sibai, Aaron D Schimmer, Mark D Minden, Hassan Sibai
This retrospective report presents the outcomes and adverse events (AEs) observed in 73 patients aged 60 years or older diagnosed with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia (Ph-negative ALL) treated with a pediatric-inspired protocol incorporating either Pegylated (PEG-ASP) or Native Asparaginase (EC-ASP). Notably, 61% of patients experienced AEs of Grade III-IV severity. The most prevalent AEs included thrombosis (35.6%), febrile neutropenia (38.4%), and transaminitis (34.2%). AEs did not translate into significant differences concerning overall survival, leukemia-free survival, or early mortality...
December 2024: Hematology (Amsterdam, Netherlands)
https://read.qxmd.com/read/38508148/pneumocystis-jiroveci-pneumonia-secondary-to-blinatumomab-therapy-a-case-report
#19
Yue Yin, Kaini Shen, Hanyu Li, Lu Zhang
Introduction With the increasing use of Blinatumomab in relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), including MRD-positive cases, awareness of its adverse effects has gradually improved. Pneumocystis jiroveci pneumonia (PCP) associated with Blinatumomab therapy is rare. Case Presentation We present a case of PCP in a patient undergoing Blinatumomab therapy. A 70-year-old female diagnosed with Philadelphia-like, CRLF2 overexpression B-cell precursor ALL received Blinatumomab as consolidation therapy after achieving complete remission with prior induction chemotherapy...
March 20, 2024: Chemotherapy
https://read.qxmd.com/read/38496108/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-in-children-a-retrospective-cohort-study-at-a-pediatric-oncology-center
#20
JOURNAL ARTICLE
Leonardo Maia Moço, Ana Fraga, Iris Maia, Marta Almeida
Background and objective Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL Ph+) is quite rare among pediatric patients. Its management has undergone significant changes in the past few years, leading to some variability in how it is approached. At the Portuguese Oncology Institute of Porto (IPOP), a tertiary oncological center, the standard of care has been aligned with the guidelines proposed by the European intergroup study of post-induction treatment of ALL Ph+ (EsPhALL). In this study, we aimed to examine the experience and outcomes related to the treatment of pediatric patients with ALL Ph+ at IPOP...
February 2024: Curēus
keyword
keyword
18110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.